| Literature DB >> 35782630 |
Bara Barakat1, Samer Schakaki2, Thomas-Alexander Vögeli3.
Abstract
Background: This study is aimed to analyze the effect of social distancing on functional outcomes (potency, continence recovery, and quality of life) on patients undergoing open radical prostatectomy (ORP) and robot-assisted radical prostatectomy (RARP) during the COVID-19 pandemic. Materials and methods: We retrospectively assessed functional outcomes of 55 consecutive patients who underwent radical prostatectomy during the COVID-19 pandemic (group A: 12 ORP and 15 RARP) and compared these data with patients from the previous year (group B: 13 ORP and 15 RARP). Propensity-score matching was performed to analyze variables associated with potency, continence recovery and compared between the groups at 1 and 3months.Entities:
Keywords: COVID-19; Open and robot-assisted radical prostatectomy; Potency; Urinary incontinence
Year: 2022 PMID: 35782630 PMCID: PMC9239351 DOI: 10.1097/CU9.0000000000000077
Source DB: PubMed Journal: Curr Urol ISSN: 1661-7649
Characteristics of 27 patients who underwent RP during social isolation June 2020-January 2021 versus 28 patients from 2019.
| RP during social isolation (Group A) | RP during previous year (Group B) |
| ||||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Variable | ORP n = 12 | RARP n = 15 | ORP n = 13 | RARP n = 15 | ORP | RARP |
| Age (yr), median (IQR) | 66.3 ± 5.2 | 66.9 ± 6.0 | 65.8 ± 5.8 | 65.6 ± 4.8 | 0.823 | 0.517 |
| BMI (kg/m2), median (IQR) | 32.7 ± 5.2 | 30.1 ± 8.3 | 33.8 ± 5.7 | 31.7 ± 6.31 | 0.620 | 0.556 |
| Mean SD total PSA (ng/mL) | 11.3 | 12.4 | 10.8 | 11.6 | 0.461 | 0.270 |
| Median transrectal ultrasound prostate volume (mL) (IQR) | 38.25 | 40.35 | 39.56 | 39.12 | 0.591 | 0.658 |
| Biopsy Gleason score, n (%) | 0.356 | 0.654 | ||||
| 6 | 3 (25) | 5 (33.3) | 4 (30.7) | 4 (26.6) | ||
| 7 | 8 (66.6) | 10 (66.6) | 9 (69.2) | 11 (73.3) | ||
| 8 | 1 (8.3) | |||||
| d’Amico group, n (%) | 0.697 | 0.754 | ||||
| Low | 4 (33.3) | 4 (26.6) | 3 (23) | 5 (33.3) | ||
| Intermediate | 7 (58.3) | 9 (60) | 8 (61.5) | 10 (66.6) | ||
| High | 1 (8.3) | 2 (13.3) | 2 (15.3) | |||
BMI = body mass index; IQR = interquartile ranges; PSA = prostate-specific antigen; ORP = open radical prostatectomy; RP = radical prostatectomy; RARP = robot-assisted radical prostatectomy.
Postoperative characteristics and complications of 27 patients who underwent RP during social isolation June 2020-January 2021 versus 28 patients from 2019.
| RP during social isolation (Group A) | RP during previous year (Group B) |
| ||||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Variable | ORP n = 12 | RARP n = 15 | ORP n = 13 | RARP n = 15 | ORP | RARP |
| Pathology Gleason score, n (%) | 0.365 | 0.271 | ||||
| 6 | 1 (8.3) | 3 (20) | 5 (38.4) | 3 (20) | ||
| 7 | 11 (91.6) | 11 (73) | 8 (61.5) | 10 (66.6) | ||
| 8 | 1 (6.6) | 2 (13.3) | ||||
| Clinical stage, n (%) | 0.535 | 0.689 | ||||
| pT2 | 7 (58.3) | 9 (60) | 6 (46.1) | 8 (53.3) | ||
| pT3 | 5 (41.6) | 6 (40) | 7 (53.8) | 7 (46.6) | ||
| Clavien complication, n (%) | 0.568 | 0.495 | ||||
| 2 (%) | 2 (16.6) | – | 1 (7.6) | 2 (13.3) | ||
| ≥3 (%) | – | 3 (20) | 1 (7.6) | 1 (6.6) | ||
| PSM rate, n (%) | 0.169 | 0.126 | ||||
| T2 (%) | 1 (8.3) | – | – | |||
| T3 (%) | 2 (16.6) | 3 (20) | 2 (7.6) | 2 (13.3) | ||
| Median urinary catheter removal time (d) | 7.6 ± 2.2 | 6.2 ± 1.9 | 7.1 ± 2.4 | 5.9 ± 1.4 | 0.593 | 0.626 |
| Mean preoperative SHIM score (SEM) at 3 mos | 14.4 ± 1.3 | 15.5 ± 1.7 | 18.2 ± 2.3 | 19.1 ± 1.6 | 0.000 | 0.000 |
| Mean preoperative ICIQ-UI SF at 3 mos | 7.3 ± 5.1 | 8.7 ± 4.6 | 11.8 ± 5.5 | 12.2 ± 3.6 | 0.045 | 0.027 |
ICIQ-SF = Incontinence Questionnaire Short Form; IQR = interquartile ranges; PSM = positive surgical margin rates; SHIM = Sexual Health Inventory for Men score.
Continence after RP during social isolation June 2020-January 2021 versus 28 patients from 2019.
| RP during social isolation (Group A) | RP during previous year (Group B) | |||
|---|---|---|---|---|
|
|
| |||
| ORP, n (%) n = 12 | ORP, n (%) n = 13 | Odds ratio (95%CI) |
| |
| At 1 mo | 3 (25) | 6 (46) | 2.85 (0.97–3.30) | 0.082 |
| At 3 mos | 4 (33.3) | 10 (76.9) | 3.54 (1.31–6.34) | 0.013 |